Collectively, our study demonstrated that a novel YAP1/SLC35B4 axis may have an important role in tumorigenesis of GC, and it could be a novel prognostic biomarker and a potential candidate for future therapeutic applications in GC. This evidence concerns the gene YAP1 and gastric cancer.